Alterations in Gas Exchange Flashcards
Clinical Manifestations and Causes of Hypoxemia
Neurological Manifestations of Hypoxemia:
Early symptoms: Apprehension, restlessness, irritability.
Progressive symptoms: Confusion, lethargy, combativeness.
Severe / late symptom: Coma.
Respiratory Manifestations of Hypoxemia:
Tachypnea and dyspnea.
Use of accessory muscles for respiration.
Intercostal and sternal retractions.
Pauses for breath between words during speech.
Cardiac Manifestations of Hypoxemia:
Tachycardia.
Blood pressure () abnormalities.
Cardiac dysrhythmias.
Cyanosis.
Cool, clammy skin.
Other Systemic Manifestations:
Diaphoresis.
Oliguria (decreased urine output).
Fatigue.
Manifestations of Long-Standing or Chronic Hypoxemia:
Digital clubbing (thickening of tissue at the base of fingernails and toenails).
Primary Causes of Hypoxemia:
Airway obstruction.
Aspiration of foreign body or secretions.
Atelectasis (alveolar collapse).
Bronchospasm.
Pulmonary edema.
Pulmonary embolism.
Hypoventilation.
Shallow respirations secondary to acute pain.
Fluid volume deficit or decreased cardiac output.
Asthma Pathophysiology and Clinical Process
Pathophysiology and Trigger Mechanism:
Airway inflammation triggers persistent bronchospasm and bronchoconstriction.
Different phenotypes serve as individual triggers for asthma attacks.
Epidemiological Risk Factors:
Strongly linked to exposure to tobacco smoke.
Markedly more prevalent in developed countries.
Clinical Manifestations:
Wheezing on auscultation.
Coughing: May produce thick mucous or present as a dry cough.
Chest tightness.
Dyspnea (shortness of breath).
Diagnostic Studies and Laboratory Testing:
Pulmonary Function Tests ().
Arterial Blood Gases ().
Basic Metabolic Panel ().
Electrocardiogram ().
Chest X-ray ().
Applying the Nursing Process (Clinical Judgment Framework):
Recognize Cues:
Assess vital signs, lung sounds across all lobes, peak flow meter readings, and chest X-ray findings.
Analyze Cues and Prioritize Hypotheses:
Presentation varies based on the severity of the asthma attack.
Top priority: Assess respiratory status and oxygenation, and rapidly treat any indications of respiratory distress.
Generate Solutions:
Primary outcome goal: Prevent further narrowing of airways to avert acute respiratory failure.
Take Actions:
Administer supplemental oxygen ().
Administer Short-Acting Beta-Agonists () for quick bronchodilation.
Administer systemic corticosteroids to resolve airway inflammation.
Evaluate Outcomes:
Monitor arterial blood gas values and oxygen saturation levels continuously.
Chronic Obstructive Pulmonary Disease (COPD) Overview and Etiology
Disease Definition:
A preventable and treatable disease characterized by persistent, usually progressive airflow limitation.
Associated with an enhanced chronic inflammatory response in the airways and lungs to noxious particles or gases.
Etiological Factors and Risk Factors:
Cigarette Smoking: The primary and major risk factor for developing COPD.
Occupational Exposure: Exposure to workplace chemicals, dusts, and fumes.
Environmental Air Pollution: Urban and indoor air pollutants.
Recurrent Respiratory Infections: Severe or recurrent lung infections during childhood.
Genetic Predisposition: Deficiency of -antitrypsin (), accounting for of COPD cases in the United States. Normal inhibits the lysis of lung tissue by elastase; deficiency leads to lung parenchymal destruction.
Age, History of Asthma, and Gender-related Factors: Natural aging processes and long-standing asthma contribute to disease onset.
Clinical Manifestations and Subtypes of COPD
Subtypes and Related Terms:
Chronic Bronchitis: Defined clinically by chronic cough and sputum production with airflow limitation. Features airway narrowing caused by overproduction of mucus and swollen tissue, with smoking as the primary risk factor.
Emphysema: Defined structurally by the destruction of alveoli, leading to impaired gas exchange, gradual destruction of alveolar septae, and damage to the pulmonary capillary bed.


Classic Phenotypic Profiles:
"Blue Bloater" (Chronic Bronchitis Presentation):
Hypoxia causing cyanosis ("blue appearance").
Digital clubbing.
Airway narrowing secondary to severe tissue swelling and mucus hypersecretion.
"Pink Panther" (Emphysema Presentation):
Pursed-lip breathing technique.
Increased retention of carbon dioxide () with maintained oxygenation ("pink appearance").
Thin body physique with prominent muscle wasting.

Primary Symptoms of COPD:
Progressive exertional dyspnea.
Chronic cough with daily sputum production.
Wheezing and feelings of chest tightness.
Barrel chest configuration (increased anterior-posterior chest diameter) and unintentional weight loss in advanced stages.
Advanced Systemic and Cardiopulmonary Signs:
Ankle edema secondary to pulmonary hypertension and right-sided heart failure.
Digital clubbing.
Hypoxemia and hypercapnia (elevated arterial ).
Oxygen saturation () dropping below in severe or advanced disease.
Compensatory polycythemia (elevated red blood cell count to compensate for chronic hypoxia).
Bluish-red discoloration of the skin due to combined cyanosis and polycythemia.
Diagnostic Evaluation and Severity Classification of COPD
Diagnostic Procedures:
Spirometry: The definitive diagnostic test used to measure lung capacity and confirm airflow obstruction.
CAPTURE Questionnaire: Screening tool to identify individuals at risk.
Arterial Blood Gases (): Evaluates baseline oxygenation and retention.
Chest X-Ray (): Assesses hyperinflation, flattened diaphragm, or concomitant pulmonary lesions.
6-Minute Walk Test: Measures exercise tolerance and exertional desaturation.
Electrocardiogram () or Echocardiogram: Used to evaluate for right ventricular hypertrophy or right-sided heart failure.
Sputum Culture and Sensitivity: Performed during infectious exacerbations to direct antibiotic selection.

Classification of COPD Severity (GOLD Criteria):
A formal diagnosis of COPD is established when a patient demonstrates a post-bronchodilator ratio of .
Severity stages based on post-bronchodilator forced expiratory volume in 1 second ():
GOLD 1 (Mild): of predicted value.
GOLD 2 (Moderate): between of predicted value.
GOLD 3 (Severe): between of predicted value.
GOLD 4 (Very Severe): of predicted value.

COPD Complications
Cor Pulmonale:
Etiology: Hypertrophy and dilatation of the right ventricle resulting from pulmonary arterial hypertension.
Mechanism: Primary cause is the constriction of pulmonary blood vessels in response to chronic alveolar hypoxia.
Result: Sustained high pressures on the right side of the heart leading to right heart failure.
Acute Respiratory Failure:
Precipitating Factors:
Abruptly discontinuing prescribed respiratory medications.
Severe acute exacerbations.
Delaying contact with healthcare providers () during symptom decline.
Acute Exacerbations:
Prognosis: As baseline severity of COPD increases, exacerbations become associated with significantly poorer long-term outcomes.
Setting of Care: Treatment occurs at home or in an acute care hospital based on severity criteria (e.g., presence of central cyanosis, accessory muscle use, peripheral edema, or severe co-morbidities).
Treatment Interventions:
Short-Acting Beta-Agonists ().
Oral or intravenous () systemic corticosteroids.
Antibiotics if the exacerbation is triggered by a bacterial infection.
Supplemental oxygen therapy.
Non-invasive positive pressure ventilation ( or ).
Interventions and Management for COPD
Oxygen Therapy Considerations:
Administer oxygen with extreme caution.
Normal drive to breathe is stimulated by hypercapnia (rising levels).
Chronic COPD patients become tolerant to high arterial levels, causing hypoxemia to become their primary respiratory drive.
Excessive elevation of partial pressure of oxygen () can abolish the hypoxic drive to breathe, leading to severe hypoventilation.
High concentrations pose a risk for toxicity.
Target oxygen saturation () for patients with COPD on chronic oxygen therapy: .
Breathing Retraining Techniques:
Pursed-Lip Breathing: Prolongs exhalation, prevents air trapping, and keeps small airways open.
Diaphragmatic Breathing: Encourages maximum use of the diaphragm muscle to reduce the work of breathing.
Airway Clearance Techniques ():
Used in conjunction with bronchodilator therapy.
Effective Huff Coughing: Conserves energy while mobilizing secretions.
Chest Physiotherapy: Combines manual percussion, vibration, and postural drainage to loosen thick pulmonary mucus.
High-Frequency Chest Wall Oscillation: Inflatable vest system delivering rapid air pulses to break up secretions.
Airway Clearance Devices: Handheld devices utilizing Positive Expiratory Pressure () to prevent airway collapse and mobilize mucus.
Pharmacotherapy Administration Devices:
Aerosol Nebulization Therapy: Converts liquid medication into a mist for deep pulmonary inhalation.
Metered-Dose Inhalers (): Deliver precise doses of medication; often used with spacers for optimal delivery.


Nutritional Management in COPD
Etiology of Malnutrition in COPD:
Systemic elevation of inflammatory mediators.
Elevated basal metabolic rate secondary to increased work of breathing.
Loss of appetite (anorexia).
Progressive weight loss serves as a key predictor of poor clinical prognosis.
Strategies to Decrease Dyspnea and Conserve Energy During Meals:
Rest for at least prior to eating.
Avoid physical exercise for before and after meals.
Administer a bronchodilator prior to eating.
Use supplemental oxygen during mealtime if required.
Consume a high-calorie, high-protein diet.
Consume small, frequent meals daily to avoid stomach distension, bloating, and early satiety.
Specific Dietary Factors to Avoid:
Foods requiring extensive chewing effort.
Physical exercises or respiratory treatments before and after meals.
Gas-forming foods that distend the abdomen and elevate the diaphragm.
Recommended Balanced Diet Composition:
High protein content.
Moderate carbohydrate content (excess carbohydrates increase production).
Moderate to high fat content.
Small, frequent meal schedule ( meals per day).
High-calorie/high-protein liquid nutritional supplements between meals.
Surgical Interventions, Gerontological, and End-of-Life Care
Surgical Treatment Options:
Lung Volume Reduction Surgery (): Surgical removal of the most hyperinflated, diseased lung tissue. Enhances overall lung and chest wall mechanics, allowing the diaphragm to regain its normal domed shape for more efficient breathing.
Bronchoscopic : Minimally invasive procedure placing one-way endobronchial valves into diseased airways, allowing trapped air to escape while blocking re-entry.
Bullectomy: Surgical excision of large bullae (distended air spaces created by destruction of alveolar walls).
Lung Transplantation: Indicated for end-stage COPD in carefully selected candidates.
Gerontological Considerations:
Normal Age-Related Physiological Changes: Gradual loss of lung elastic recoil, structural lung changes (smaller, rounded lungs), reduced count of functional alveoli, higher rates of exacerbations and hospitalizations. Some emphysematous changes occur naturally in aging lungs even in non-smokers.
Co-morbidities: High prevalence of cardiovascular disease (), recurrent respiratory infections, osteoporosis, mood/psychological changes, cognitive decline, and lung cancer.
Challenges: Functional muscle weakness, complex multi-drug regimens (inhalers, home , systemic medications), and markedly reduced quality of life.
End-of-Life Care Considerations:
Referrals to medical social workers for comprehensive care coordination.
Development and documentation of advance directives.
Palliative Care: Symptom control, pain management, and optimizing quality of life.
Hospice Care: Holistic support for patients, families, and caregivers during final transitions and end-of-life decisions.
Nursing Process for COPD
Comprehensive Assessment:
Subjective Assessment:
Past Medical History (): Tobacco smoke exposure, environmental toxins, prior lung infections, previous hospitalizations.
Family History (): Chronic obstructive pulmonary disease or other chronic respiratory conditions.
Weight Changes: Unintentional weight loss or changes in appetite.
Functional Capacity: Activity tolerance, independent performance of Activities of Daily Living () and Instrumental Activities of Daily Living ().
Current symptom profile.
Objective Assessment:
General: Restlessness, mental status/cognition, upright or tripod positioning.
Skin & Extremities: Cyanosis, peripheral edema, digital clubbing.
Respiratory: Respiratory effort, auscultated breath sounds, anteroposterior () chest diameter (barrel chest).
Cardiovascular: Heart rate and rhythm, heart sounds, jugular venous distention (), presence of gallop sound.
Abdomen & Musculoskeletal: Ascites, hepatomegaly, generalized muscle atrophy.
Diagnostic Findings: values, hemoglobin and hematocrit (), pulse oximetry, results, chest X-ray findings.
Primary Clinical Nursing Diagnoses / Problems:
Impaired respiratory function / gas exchange.
Activity intolerance.
Nutritionally compromised status.
Ineffective individual or family coping.
Planning and Expected Patient Goals:
Symptom relief.
Improved capacity to complete .
Increased exercise tolerance.
Absence of COPD-related complications.
Adequate knowledge and execution of long-term treatment regimens.
Enhanced overall quality of life and prevention of rapid disease progression.
Health Promotion and Nursing Implementation:
Health Promotion Strategies:
Absolute smoking cessation (primary priority intervention).
Avoidance of sick contacts and infectious exposures.
Tailored exercise programs and maintaining healthy body weight.
Early identification and treatment of acute respiratory infections.
Complete immunization schedule (influenza, COVID-19, pneumococcal vaccines).
Acute Care Nursing Interventions:
Monitor respiratory status: Vital signs, , lung sounds, respiratory effort, and signs of worsening hypoxia.
Daily weight monitoring and strict intake and output ().
Administer prescribed and PRN medications and oxygen therapy.
Encourage incentive spirometry usage.
Position patient in High Fowler's position to maximize chest expansion.
Administer fluids and encourage oral fluid intake to thin secretions.
Schedule rest periods and restrict unnecessary visitors to conserve energy.
Ensure adequate nutritional intake using small, frequent meals and supplements.
Implement comfort measures and reduce patient anxiety.
Promptly notify healthcare provider () of status changes; prepare for emergency resuscitation and respiratory support as indicated.
Provide continuous psychosocial support.
Evaluation Criteria:
Maintenance of airway patency.
Adequate oxygenation metrics.
Decreased breathing effort and improved breath sounds.
Demonstrated patient knowledge and treatment compliance.
Pneumonia and Pulmonary Edema
Pneumonia Clinical Features and Impact:
Physiological and Psychosocial Impact: Causes acute exacerbation of underlying co-morbid conditions.
Aging Adults: Significantly increased incidence in older adults, frequently requiring acute hospitalization.
Immunocompromised Patients: Highly vulnerable to opportunistic fungal and viral pulmonary infections.
Clinical Presentation: Cough, dyspnea, pleuritic chest pain, and adventitious lung sounds (crackles, rhonchi).
Diagnostic Gold Standard: Chest X-ray () is the definitive diagnostic method.

Applying the Nursing Process for Pneumonia:
Recognize Cues: Gather history of pulmonary disorders; assess present symptoms including fever, dyspnea, cough, pleuritic chest pain, headache, myalgia, and mealtime fatigue.
Analyze Cues and Prioritize Hypotheses: Identify respiratory distress, hypoxemia, or signs of systemic sepsis (e.g., acute mental status changes). Prioritize airway patency, work of breathing, and pulse oximetry assessments.
Generate Solutions: Establish interdisciplinary goals focused on oxygenation, tissue perfusion, and fluid balance.
Take Actions:
Coach effective coughing and deep breathing exercises.
Titrate oxygen therapy, reposition frequently, and provide humidified oxygen to thin dry secretions.
Increase oral fluid intake to compensate for increased insensible fluid loss.
Elevate head of bed ().
Consult respiratory therapy, physical therapy, and nutritional services.
Evaluate Outcomes:
Assess for clinical improvement within of commencing antibiotic therapy.
Re-assess vital signs, oxygen saturation, baseline mental status, lung sounds, and return of self-care ability.
Pulmonary Edema Pathophysiology and Clinical Process:
Pathophysiology: Life-threatening pulmonary emergency characterized by rapid accumulation of fluid in the alveolar and interstitial spaces of the lungs. Associated with high clinical mortality rates.
Etiology: Systolic heart failure, diastolic heart failure, or renovascular hypertension.
Clinical Manifestations:
Extreme shortness of breath and gasping for air.
Severe anxiety, confusion, and motor agitation.
Hypertension accompanied by jugular venous distention ().
Auscultation reveals adventitious lung sounds (widespread crackles), or gallops, and abdominal tenderness.
Diagnostics: Basic metabolic panel (), complete blood count () to rule out anemia/sepsis, pulse oximetry, , B-type natriuretic peptide (), , and chest X-ray.
Nursing Interventions:
Immediately elevate head of bed ().
Administer high-flow oxygen therapy.
Implement anxiety-reduction strategies.
Administer intravenous diuretics as ordered.
Maintain strict intake and output () monitoring.
Initiate continuous cardiac monitoring.
Evaluation: Evaluate improvement in oxygenation levels and reduction in patient anxiety.